Immunological mechanisms involved in psoriasis
dc.contributor.author | Griffiths, Christopher E. M. | en_US |
dc.contributor.author | Voorhees, John J. | en_US |
dc.date.accessioned | 2006-09-11T18:23:48Z | |
dc.date.available | 2006-09-11T18:23:48Z | |
dc.date.issued | 1992-07 | en_US |
dc.identifier.citation | Griffiths, Christopher E. M.; Voorhees, John J.; (1992). "Immunological mechanisms involved in psoriasis." Springer Seminars in Immunopathology 13 (3-4): 441-454. <http://hdl.handle.net/2027.42/46935> | en_US |
dc.identifier.issn | 0344-4325 | en_US |
dc.identifier.issn | 1432-2196 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46935 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1411908&dopt=citation | en_US |
dc.description.abstract | The past decade has borne witness to tremendous advances in our knowledge of the pathogenesis of psoriasis and the weight of evidence is now on the side of the T cell as being an integral mediator of this process. Advances in molecular technology have enabled direct in vivo measurement of cytokines and, although no animal model exists for the study of psoriasis, the use of cyclosporine has served as an excellent investigatory tool. The utilization of therapeutics to study psoriatic mechanisms is an unusual approach in that one must derive conclusions from disappearance of measurable factors such as cytokines and assume that these same factors are vital to the initiation and maintenance of a psoriatic plaque. Studying disease evolution using the Koebner phenomenon or relapse following treatment would supply a more accurate picture of initiating events. Based on the immune hypothesis, therapeutic modalities which are now entering the arena include T cell vaccination, particularly if psoriasis-specific T cell receptor V β -restricted clones can be isolated from psoriatic plaques. | en_US |
dc.format.extent | 1000483 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; Springer-Verlag New York, Inc. | en_US |
dc.subject.other | Internal Medicine | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Immunology | en_US |
dc.title | Immunological mechanisms involved in psoriasis | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pathology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan Medical Center, 1910 Taubman Center, 48109-0314, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan Medical Center, 1910 Taubman Center, 48109-0314, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 1411908 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46935/1/281_2004_Article_BF00200540.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF00200540 | en_US |
dc.identifier.source | Springer Seminars in Immunopathology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.